Level Bio AB (publ) (NGM:LEVBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2640
+0.0100 (3.94%)
At close: Sep 3, 2026

Level Bio AB Statistics

Total Valuation

Level Bio AB has a market cap or net worth of SEK 18.06 million. The enterprise value is 17.98 million.

Market Cap18.06M
Enterprise Value 17.98M

Important Dates

The next estimated earnings date is Friday, October 23, 2026.

Earnings Date Oct 23, 2026
Ex-Dividend Date n/a

Share Statistics

Level Bio AB has 68.40 million shares outstanding.

Current Share Class 68.40M
Shares Outstanding 68.40M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 16.23%
Owned by Institutions (%) 13.86%
Float 32.03M

Valuation Ratios

The trailing PE ratio is 3.80.

PE Ratio 3.80
Forward PE n/a
PS Ratio 0.53
PB Ratio 2.72
P/TBV Ratio 2.73
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 3.78
EV / Sales 0.52
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.70

Current Ratio 0.70
Quick Ratio 0.33
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -17.60

Financial Efficiency

Return on equity (ROE) is 111.36% and return on invested capital (ROIC) is -50.10%.

Return on Equity (ROE) 111.36%
Return on Assets (ROA) -5.58%
Return on Invested Capital (ROIC) -50.10%
Return on Capital Employed (ROCE) -19.89%
Weighted Average Cost of Capital (WACC) 11.35%
Revenue Per Employee 3.44M
Profits Per Employee 475,666
Employee Count10
Asset Turnover 2.14
Inventory Turnover 4.26

Taxes

In the past 12 months, Level Bio AB has paid 126,405 in taxes.

Income Tax 126,405
Effective Tax Rate 2.59%

Stock Price Statistics

The stock price has decreased by -33.33% in the last 52 weeks. The beta is 1.29, so Level Bio AB's price volatility has been higher than the market average.

Beta (5Y) 1.29
52-Week Price Change -33.33%
50-Day Moving Average 0.27
200-Day Moving Average 0.32
Relative Strength Index (RSI) 48.99
Average Volume (20 Days) 26,240

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Level Bio AB had revenue of SEK 34.37 million and earned 4.76 million in profits.

Revenue34.37M
Gross Profit 17.87M
Operating Income -1.43M
Pretax Income 4.88M
Net Income 4.76M
EBITDA -303,534
EBIT -1.43M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has 78,000 in cash and no debt, with a net cash position of 78,000 or 0.00 per share.

Cash & Cash Equivalents 78,000
Total Debt n/a
Net Cash 78,000
Net Cash Per Share 0.00
Equity (Book Value) 6.65M
Book Value Per Share n/a
Working Capital -3.53M
Full Balance Sheet

Cash Flow

Operating Cash Flow -381,553
Capital Expenditures n/a
Depreciation & Amortization 1.13M
Net Borrowing 345,675
Free Cash Flow -381,553
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross margin is 51.98%, with operating and profit margins of -4.17% and 13.84%.

Gross Margin 51.98%
Operating Margin -4.17%
Pretax Margin 14.21%
Profit Margin 13.84%
EBITDA Margin -0.88%
EBIT Margin -4.17%
FCF Margin n/a

Dividends & Yields

Level Bio AB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 26.34%
FCF Yield -2.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1